Indication
Gallbladder Adenocarcinoma
3 clinical trials
2 products
2 drugs
Clinical trial
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-12-01
Product
HIPECClinical trial
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual DiseaseStatus: Recruiting, Estimated PCD: 2026-12-01
Drug
AtezolizumabClinical trial
A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder CancerStatus: Active (not recruiting), Estimated PCD: 2021-03-02
Drug
AN0025Product
Guadecitabine